# Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis

> **NCT04801719** · NA · COMPLETED · sponsor: **Brno University Hospital** · enrollment: 76 (actual)

## Conditions studied

- Radiofrequency Ablation
- Biliary Tract Cancer
- Stent Complication
- Brachytherapy

## Interventions

- **DEVICE:** Habib™ EndoHPB; Boston Scientific, US; former EMcision Ltd., UK

## Key facts

- **NCT ID:** NCT04801719
- **Lead sponsor:** Brno University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-04
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04801719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04801719, "Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04801719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*